Alzheimer’s: Early trial shows new drug solanezumab could slow progression of disease

Long-frustrated hopes of finding a viable treatment for Alzheimer’s have received a boost, after promising early trial results indicated an experimental new drug can slow the progression of the disease.
Source: The Independent - Science - Category: Science Tags: Health News Source Type: news
More News: Health | Science